rdf:type |
|
lifeskim:mentions |
umls-concept:C0109317,
umls-concept:C0205087,
umls-concept:C0521447,
umls-concept:C0752312,
umls-concept:C1150579,
umls-concept:C1333340,
umls-concept:C1366882,
umls-concept:C1370600,
umls-concept:C1514873,
umls-concept:C1521840,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C1705767,
umls-concept:C1705791,
umls-concept:C1879547
|
pubmed:issue |
12
|
pubmed:dateCreated |
2009-11-20
|
pubmed:abstractText |
Sustained extracellular signal-regulated kinase (ERK)-signaling plays a critical role in T-cell-mediated IL-2 production. Although many downstream targets are known for ERK, details remain unknown about which molecules play functional roles in IL-2 production. Here, we addressed this question using proteomic analysis of nuclear proteins from TCR-activated T cells and identified hnRNP-K as one of the ERK targets essential for IL-2 production. hnRNP-K was previously shown by others to be a direct substrate of ERK and form complexes with multiple signaling proteins as well as DNA and RNA. Our data showed a clear ERK-dependent increase in one form of hnRNP-K after TCR stimulation. Small interfering RNA-mediated gene knockdown of hnRNP-K expression abrogated IL-2 production by T cells. Moreover, reduction of hnRNP-K expression caused a notable increase in proteolysis of Vav1, a binding target of hnRNP-K. Since Vav1 is an essential molecule for T-cell activation, the data suggest that ERK signaling is required for T-cell activation partly by inhibiting activation-induced proteolysis of Vav1.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1460-2377
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1351-61
|
pubmed:dateRevised |
2011-3-3
|
pubmed:meshHeading |
pubmed-meshheading:19880579-Animals,
pubmed-meshheading:19880579-Enzyme Activation,
pubmed-meshheading:19880579-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:19880579-Heterogeneous-Nuclear Ribonucleoprotein K,
pubmed-meshheading:19880579-Humans,
pubmed-meshheading:19880579-Interleukin-2,
pubmed-meshheading:19880579-Jurkat Cells,
pubmed-meshheading:19880579-Lymphocyte Activation,
pubmed-meshheading:19880579-Mice,
pubmed-meshheading:19880579-Mice, Inbred BALB C,
pubmed-meshheading:19880579-Proto-Oncogene Proteins c-vav,
pubmed-meshheading:19880579-Receptors, Antigen, T-Cell,
pubmed-meshheading:19880579-Signal Transduction,
pubmed-meshheading:19880579-T-Lymphocytes
|
pubmed:year |
2009
|
pubmed:articleTitle |
hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation.
|
pubmed:affiliation |
Department of Medicine, Immunotherapy Center, Medical College of Georgia, Augusta, GA 30912-2600, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|